Chemoresistance

1 paper

Animals1

Funding

1 grant since 2026

National Cancer InstituteUS$390.4k

Overcoming ovarian cancer chemoresistance by co-targeting senescence and apoptosis
National Cancer InstituteHarvard UniversityUS$390.4k2026

Latest

4 in 12 months

Ageing Research Reviews29 Mar

S100A8/A9 as a central hub in inflammaging: Cross-system mechanisms

ReviewInflammation

Cellular Oncology23 Mar

Targeting senescence-like tumor-associated macrophages sensitizes chemotherapy in triple-negative breast cancer

Experiments in miceInterventions

Pharmaceutics28 Jan

Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain

ReviewNRF2–KEAP1 antioxidant response

Translational Oncology7 Jan

First functional evidence that a rare germline TP53β variant drives senescence-associated immune suppression and impairs apoptosis and cell migration in breast cancer patients

Cohort study in peopleApoptosis

Cell Reports23 Feb

Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination

Experiments in miceSenescence-associated secretory phenotype (SASP)